RIGL   $26.04  3.99% Market Closed After Close 26.04 0.0

Rigel Pharmaceuticals Inc

EMA (20): 2024-11-06 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2024-11-05 the price crossed up the moving average line and demonstrates an upside trend.

EMA (100): 2024-08-12 the price crossed up the moving average line and demonstrates an upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: entrance to the overbought zone.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: main and signal line crossing.

Trend Type turning up
Power strong
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 59.58%
EMA (20) date of signal Nov. 6, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 65.97%
EMA (50) date of signal Nov. 5, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 112.96%
EMA (100) date of signal Aug. 12, 2024, 3 a.m.
RSI Signals bullish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 21, 2024, 3 a.m.
MACD Signals bullish weakening
MACD Yield 5.83%
MACD date of signal Nov. 18, 2024, 3 a.m.
Stochastic Signals bullish reversal
Stochastic Yield 0.0
Stochastic date of signal Nov. 21, 2024, 3 a.m.
Updated Nov. 21, 2024, 11:03 p.m.